Study Summary
A Study of Metabolically Armed BCMA CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Plasma Cell Neoplasms.
Want to learn more about this trial?
Request More InfoInterventions
Metabolically Armed BCMA CAR-T cells.DRUG
Each subject receive metabolically armed BCMA CAR- T cells by intravenous infusion.
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Anhui Provincial Hospital | Hefei | Anhui | China |